Brind.

Cellebrite DI Ltd. may benefit from Trump-era tariffs and onshoring trends, coinciding with Thomas E. Hogan's appointment as CEO.

4 reports, 4 independent Updated Aug 25
Gone quiet Reached 4 outlets in its first 24 hours
Reports
4
Developments
3
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Cellebrite DI Ltd. may benefit from Trump-era tariffs and onshoring trends, coinciding with Thomas E. Hogan's appointment as CEO.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Cellebrite announced that Tom Hogan has been replaced as CEO of the company.Sub-event
  2. Kevin Hogan was appointed CEO of Corebridge Financial on August 13, 2025.Sub-event
  3. Cellebrite DI Ltd. benefits from Trump tariffs; Hogan appointed CEO.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Insider MonkeyCraig-Hallum Reiterates a Buy Rating on Cellebrite DI Ltd. (CLBT) Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the best stocks under $20 to buy for the long term. On August 19, Craig-Hallum analyst Jef
  • Simply Wall St.Will Cellebrite DI's (CLBT) Return to Profitability and New CEO Shape Its Investment Story? Cellebrite DI announced its half-year 2025 results, reporting revenue of US$220.83 million, a turnaround to
  • Motley FoolCellebrite Begins Its Next Chapter Cellebrite continued to see solid growth in the second quarter of 2025, led by a big jump in free cash flow. The company named interim CEO Tom Hogan to take on the
  • GlobeNewswireCellebrite Announces Second-Quarter 2025 Results Thomas E. Hogan Named CEO ARR grew 21% to $418.9 million; Revenue grew 18% to $113.3 million Net income of $19.5 million supports non-GAAP net income